Janux Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 02/14/2025 | 10.37 M | $554.98 M | 13.09% | 18.97% |
| FMR LLC | 02/13/2025 | 8.67 M | $464.19 M | 10.80% | 15.87% |
| JANUS HENDERSON GROUP PLC | 02/14/2025 | 3.56 M | $190.62 M | 41.17% | 6.52% |
| PARADIGM BIOCAPITAL ADVISORS LP | 02/14/2025 | 3.52 M | $188.25 M | 46.46% | 6.44% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 02/14/2025 | 3.06 M | $163.93 M | 47.55% | 5.60% |
| BLACKROCK FUNDING, INC. /DE | 02/07/2025 | 2.73 M | $145.94 M | 12.51% | 4.99% |
| VANGUARD GROUP INC | 02/11/2025 | 2.14 M | $114.38 M | 15.61% | 3.91% |
| CORMORANT ASSET MANAGEMENT, LP | 02/14/2025 | 2.10 M | $112.43 M | 100.00% | 3.84% |
| WOODLINE PARTNERS LP | 02/14/2025 | 1.85 M | $99.17 M | 15.74% | 3.39% |
| ECOR1 CAPITAL, LLC | 02/14/2025 | 1.47 M | $78.69 M | 0.00% | 2.69% |
| LORD, ABBETT & CO. LLC | 02/14/2025 | 1.27 M | $67.88 M | 80.22% | 2.32% |
| LOGOS GLOBAL MANAGEMENT LP | 02/14/2025 | 1.25 M | $66.93 M | 25.00% | 2.29% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 02/14/2025 | 1.11 M | $59.43 M | 596.26% | 2.03% |
| HOLOCENE ADVISORS, LP | 02/14/2025 | 1.02 M | $54.35 M | 100.00% | 1.86% |
| PERCEPTIVE ADVISORS LLC | 02/14/2025 | 817,895 | $43.79 M | 100.00% | 1.50% |
| ORBIMED ADVISORS LLC | 02/14/2025 | 758,566 | $40.61 M | -39.73% | 1.39% |
| AVIDITY PARTNERS MANAGEMENT LP | 02/14/2025 | 741,900 | $39.72 M | 32.01% | 1.36% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/12/2025 | 714,956 | $38.29 M | 7.90% | 1.31% |
| POINT72 ASSET MANAGEMENT, L.P. | 02/14/2025 | 621,383 | $33.27 M | 56.96% | 1.14% |
| WELLINGTON MANAGEMENT GROUP LLP | 02/12/2025 | 535,396 | $28.67 M | 3,592.90% | 0.98% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 02/14/2025 | 515,646 | $27.61 M | 100.00% | 0.94% |
| FRANKLIN RESOURCES INC | 02/12/2025 | 497,287 | $26.62 M | 2,519.64% | 0.91% |
| NATIONALE-NEDERLANDEN POWSZECHNE TOWARZYSTWO EMERYTALNE S.A. | 02/18/2025 | 429,392 | $22.99 M | -8.98% | 0.79% |
| PICTET ASSET MANAGEMENT HOLDING SA | 02/12/2025 | 384,797 | $20.60 M | 100.00% | 0.70% |
| FIRST TURN MANAGEMENT, LLC | 02/14/2025 | 383,602 | $20.54 M | 100.00% | 0.70% |
| GOLDMAN SACHS GROUP INC | 02/11/2025 | 380,347 | $20.36 M | 20.46% | 0.70% |
| ALYESKA INVESTMENT GROUP, L.P. | 02/14/2025 | 344,916 | $18.47 M | 69.76% | 0.63% |
| READYSTATE ASSET MANAGEMENT LP | 02/14/2025 | 339,639 | $18.18 M | 950.38% | 0.62% |
| PROSIGHT MANAGEMENT, LP | 02/14/2025 | 329,768 | $17.66 M | 60.86% | 0.60% |
| HOLOCENE ADVISORS, LP | 02/14/2025 | 316,600 | $16.95 M | 100.00% | 0.58% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 02/14/2025 | 313,782 | $16.80 M | 100.00% | 0.57% |
| INVESCO LTD. | 02/13/2025 | 284,662 | $15.24 M | 2,764.38% | 0.52% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 02/06/2025 | 273,135 | $14.62 M | 16.63% | 0.50% |
| BARCLAYS PLC | 02/13/2025 | 263,970 | $14.13 M | 51.65% | 0.48% |
| SOFINNOVA INVESTMENTS, INC. | 02/14/2025 | 253,262 | $13.56 M | 53.71% | 0.46% |
| VICTORY CAPITAL MANAGEMENT INC | 02/06/2025 | 242,409 | $12.98 M | 714.96% | 0.44% |
| TRI LOCUM PARTNERS LP | 02/14/2025 | 236,407 | $12.66 M | 100.00% | 0.43% |
| BIOIMPACT CAPITAL LLC | 02/14/2025 | 230,000 | $12.31 M | 34.42% | 0.42% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 02/14/2025 | 229,390 | $12.28 M | 100.00% | 0.42% |
| UBS GROUP AG | 02/14/2025 | 225,090 | $12.05 M | 315.34% | 0.41% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 02/14/2025 | 223,100 | $11.94 M | 87.48% | 0.41% |
| SKANDINAVISKA ENSKILDA BANKEN AB (PUBL) | 02/10/2025 | 205,167 | $10.77 M | 492.16% | 0.38% |
| ROCK SPRINGS CAPITAL MANAGEMENT LP | 02/14/2025 | 204,466 | $10.95 M | 100.00% | 0.37% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 02/14/2025 | 200,000 | $10.71 M | 100.00% | 0.37% |
| JPMORGAN CHASE & CO | 02/12/2025 | 191,603 | $10.26 M | 941.77% | 0.35% |
| RATAN CAPITAL MANAGEMENT LP | 02/14/2025 | 179,307 | $9.60 M | 522.59% | 0.33% |
| SIREN, L.L.C. | 02/14/2025 | 175,000 | $9.37 M | 100.00% | 0.32% |
| RHENMAN & PARTNERS ASSET MANAGEMENT AB | 02/13/2025 | 170,000 | $9.10 M | 59.11% | 0.31% |
| UBS ASSET MANAGEMENT AMERICAS INC | 02/14/2025 | 165,737 | $8.87 M | 532.73% | 0.30% |
| ARTIA GLOBAL PARTNERS LP | 02/14/2025 | 162,976 | $8.73 M | 100.00% | 0.30% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Janux Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 228 institutional investors and hedge funds held shares of Janux Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.37 M
FMR LLC: 8.67 M
JANUS HENDERSON GROUP PLC: 3.56 M
Paradigm Biocapital Advisors LP: 3.52 M
ADAGE CAPITAL PARTNERS GP, L.L.C.: 3.06 M
BlackRock Funding, Inc. /DE: 2.73 M
117.44% of Janux Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 64.32 M shares in the last 24 months. This purchase volume represents approximately $3.44 B in transactions.